β-Arrestin-1 is required for adaptive β-cell mass expansion during obesity

Nat Commun. 2021 Jun 7;12(1):3385. doi: 10.1038/s41467-021-23656-1.

Abstract

Obesity is the key driver of peripheral insulin resistance, one of the key features of type 2 diabetes (T2D). In insulin-resistant individuals, the expansion of beta-cell mass is able to delay or even prevent the onset of overt T2D. Here, we report that beta-arrestin-1 (barr1), an intracellular protein known to regulate signaling through G protein-coupled receptors, is essential for beta-cell replication and function in insulin-resistant mice maintained on an obesogenic diet. Specifically, insulin-resistant beta-cell-specific barr1 knockout mice display marked reductions in beta-cell mass and the rate of beta-cell proliferation, associated with pronounced impairments in glucose homeostasis. Mechanistic studies suggest that the observed metabolic deficits are due to reduced Pdx1 expression levels caused by beta-cell barr1 deficiency. These findings indicate that strategies aimed at enhancing barr1 activity and/or expression in beta-cells may prove useful to restore proper glucose homeostasis in T2D.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Glucose / metabolism
  • Cell Proliferation
  • Diabetes Mellitus, Type 2 / metabolism*
  • Diabetes Mellitus, Type 2 / pathology
  • Diet, High-Fat / adverse effects
  • Disease Models, Animal
  • Homeodomain Proteins / metabolism
  • Humans
  • Insulin Resistance
  • Insulin-Secreting Cells / pathology*
  • Male
  • Mice
  • Mice, Knockout
  • Obesity / etiology
  • Obesity / metabolism*
  • Obesity / pathology
  • Trans-Activators / metabolism
  • beta-Arrestin 1 / genetics
  • beta-Arrestin 1 / metabolism*

Substances

  • Arrb1 protein, mouse
  • Blood Glucose
  • Homeodomain Proteins
  • Trans-Activators
  • beta-Arrestin 1
  • pancreatic and duodenal homeobox 1 protein